Acute Effects of Cold Exposure on Cognitive Function
1 other identifier
interventional
40
1 country
1
Brief Summary
This is a randomized controlled human exposure crossover study. Investigators aims to assess the acute effects of low-temperature exposure on cognitive function and the underlying mechanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2024
CompletedStudy Start
First participant enrolled
October 16, 2024
CompletedFirst Posted
Study publicly available on registry
October 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedFebruary 27, 2025
February 1, 2025
1 month
October 15, 2024
February 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Results of Stroop Tests
Investigators plan to measure the changes of cognitive function using Stroop Test. The time taken to complete the test could reflect cognitive function, and a shorter time means better cognitive function.
before exposure and immediately after the exposure session
Secondary Outcomes (5)
Results of simple reaction time
before exposure and immediately after the exposure session
Activated brain regions demonstrating neural activity related to the high temperature exposure
1 hour after exposure session
Activated brain regions demonstrating neural connectivity related to the high temperature exposure
1 hour after exposure session
Activated brain regions demonstrating neural synchronization related to the high temperature exposure
1 hour after exposure session
Changes of skin temperature
Skin temperature will be examined during the 2-hour exposure session (i.e., 1:00 P.M. to 3:00 P.M. on the day of the exposure session)
Other Outcomes (8)
Differences in RNA expression levels detected in serum transcriptomics between the two exposures
1 hour after the exposure session
Change in brain-derived neurotrophic factor (BDNF) concentrations
1:00 P.M. on the day of the exposure session, 1 hour after the exposure session
Change in glial cell line-derived neurotrophic factor (GDNF) concentrations
1:00 P.M. on the day of the exposure session, 1 hour after the exposure session
- +5 more other outcomes
Study Arms (2)
Low temperature (15℃) group
EXPERIMENTALSubjects in the exposure group will be exposed to low temperature (15℃) for about 2 hours in a chamber.
Moderate temperature (22℃) group
EXPERIMENTALSubjects in the exposure group will be exposed to moderate temperature (22℃) for about 2 hours in a chamber.
Interventions
The exposure group will be exposed to low temperature (15℃) in a chamber for about 2 hours, resting during the whole period.
The exposure group will be exposed to thermoneutral temperature (22℃) in a chamber for about 2 hours, resting during the whole period.
Eligibility Criteria
You may qualify if:
- Living in Shanghai during the study period;
- Body mass index \> 18.5 and ≤ 28;
- right-handed;
- receiving or having received higher education;
- with the ability to read and understand Chinese smoothly.
You may not qualify if:
- Smoking and alcohol abuse;
- Current drug and dietary supplements intake;
- Subjects with allergic diseases, such as allergic rhinitis, allergic asthma, and atopy;
- Subjects with cardiovascular diseases, such as congenital heart disease, pulmonary heart disease, and hypertension;
- Subjects with respiratory diseases, such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease;
- Subjects with chronic diseases, such as diabetes, chronic hepatitis, and kidney disease;
- Subjects who have a history of major surgery due to the cardiovascular, cerebrovascular, respiratory, or neurological diseases;
- Subjects with neurologic disorders, such as stroke, traumatic brain injury, epilepsy, and schizophrenia;
- Abnormal spirometry (FEV1 and FVC ≤ 75% of predicted and FEV1/FVC ≤ 0.65);
- Subjects with color vision disabilities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (1)
Department of Environmental Health, School of Public Health, Fudan University
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Haidong Kan, PhD
Fudan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 15, 2024
First Posted
October 23, 2024
Study Start
October 16, 2024
Primary Completion
November 16, 2024
Study Completion (Estimated)
December 31, 2026
Last Updated
February 27, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share